1–2 of 2 results for oligonucleotide
Baseline Characteristics in the Phase 2 GOLDEN Study of IONIS-FB-LRx, an Investigational Antisense Oligonucleotide Designed to Treat AMD-Associated Geographic Atrophy
Glenn J. Jaffe, MD
Annual Meeting Talks
2022
Episode 147: CEP290 mRNA intravitreal therapy for LCA
Jayanth Sridhar, MD
Member Podcasts
2018